Industry | 科学研究和技术服务业 | ||||||||||||||||||||||||
Company Introduction | 阿拉丁:开启科学奇迹》 在阿拉丁,我们将尖端科学与不懈的进步融合在一起。我们成立于2008年,以其卓越的试剂而闻名,从化学试剂、生化试剂、配体到蛋白质和抗体。我们拥有700多名员工,拥有三个制造设施和两个研发中心,我们对卓越科学和产品质量的承诺坚定不移。 我们的愿景 阿拉丁是科技和创新领域的灯塔,象征着由科学发现驱动的未来。我们相信科学的变革力量——它改变社会、提升生活的能力。我们的精神体现在我们创造的每一种产品和提供的每一项服务中。 精确驱动的研究 在研发领域,精确性是最重要的。我们的生命科学工具旨在实现无与伦比的准确性,确保研究不仅高效,而且异常精确。我们的目标是明确而坚定的:提供精确指导的结果,并通过卓越的结果建立信任。 创新是我们的核心 创新是阿拉丁旅程的核心。它推动我们进入新的领域,不断推动我们超越平凡。我们利用数据的巨大潜力,打破传统界限,开拓创新,真正改善生活。加入我们的变革之旅,我们的每一步都朝着更具创新性、更光明的未来迈进。 | ||||||||||||||||||||||||
Main Business | 科研试剂的研发、生产及销售 | ||||||||||||||||||||||||
Legal Representative | 徐久振 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 赵新安 | ||||||||||||||||||||||||
Solicitors | 上海市锦天城律师事务所 | ||||||||||||||||||||||||
Auditors | 大华会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 021-50560989 | ||||||||||||||||||||||||
Fax No | 021-50323701 | ||||||||||||||||||||||||
Website | www.aladdin-e.com | ||||||||||||||||||||||||
aladdindmb@163.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 26/10/2020 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ 0.490 | ||||||||||||||||||||||||
DPS(RMB)* | ¥ 0.300 | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 4.971 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 4.596B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |